Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ("Tanabe Pharma", "MTPC" or "the Company") ...

The Osaka-based firm has a pipeline of drugs relating to the central nervous system, immuno-inflammation and oncology ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it ...

Now, Pennsylvania Gov. Josh Shapiro hopes to change that and take on the sector's top dogs with $30M allocated for life ...

The first local company to reach "unicorn" status in 2025 isn't a tech startup, unlike most of the "unicorns" Greater Boston ...

Q4 2024 Earnings Call Transcript January 29, 2025 Operator: Good day. And thank you for standing by. Welcome to BXP’s Q 4 ...

Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.